An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a forum asked whether the mild appetite effects they felt after their first 0.25 mg Wegovy (semaglutide) shot lasted longer after their second or third doses. They said the first two days after that initial tiny shot they noticed a slight drop in appetite — not dramatic, just enough that eating around maintenance felt easier — and they wondered if that effect would deepen or last longer with subsequent injections. Wegovy is the brand name for a drug whose active ingredient is semaglutide. Semaglutide is a synthetic version of a natural hormone your gut makes after eating that helps signal fullness to the brain and slows how fast the stomach empties. At the low starting dose of 0.25 mg, people usually don’t get the full appetite-suppressing effect; the dose is meant as a gentle introduction so the body adjusts before the doctor increases it over weeks. What we can say from reports and clinical practice is that the drug’s effects are dose-dependent and cumulative to some extent. That means the tiny 0.25 mg shot is often barely noticeable for many people, and any mild change can feel stronger to the person experiencing it. In clinical trials, larger maintenance doses produced clearer and more sustained reductions in appetite and weight. Anecdotal reports like this one suggest some people do notice a bit more or longer-lasting suppression after a second or third injection, but that is personal and can vary a lot. The forum post is a single-person observation, not a controlled study, so it can’t prove a general rule. Why this matters is simple: many people start on low doses and hope they’ll get even small helpful changes right away. If your goal is weight control or managing overeating, it’s useful to know that initial mild effects might increase as you move up to the prescribed therapeutic doses. It also helps set expectations: don’t assume one tiny shot will fix appetite long-term, but it might give you a short window of slightly easier control while your care team adjusts dosing. There are important caveats. Side effects — especially nausea, constipation, and stomach discomfort — are common when doses increase, and not everyone can tolerate higher amounts. Semaglutide is a prescription medication; dosing schedules are designed by clinicians, and changes should be made under their guidance. People with certain medical histories or pregnant people should not use it. Finally, individual responses vary widely, and a single forum report is anecdote, not evidence. If you’re considering or already taking it and notice changes, talk with your prescriber about what to expect next. Bottom line: a tiny first shot can give a brief, mild appetite dip for some people, and effects often become clearer at higher, clinically effective doses — but personal experiences differ and medical guidance matters.
Source: r/Semaglutide